Your session is about to expire
← Back to Search
Outpatient Stewardship Program for Antibiotic Overuse in Pediatric Infections (BIOS Trial)
BIOS Trial Summary
This trialwill examine how to reduce unnecessary antibiotics in pediatric settings to improve health and prevent resistance.
BIOS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.BIOS Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 6 months and 12 years old.My child has a complex chronic condition and/or was treated with antibiotics in the last 30 days.
- Group 1: Delayed Intervention (Control)
- Group 2: Early Intervention
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the ultimate goal of this experiment?
"This clinical trial seeks to assess the implementation of a particular intervention over 36 months before randomization, and 27 months following its initiation. Secondary outcome measures include rate of broad-spectrum antibiotic prescribing by practice setting, rate of antibiotic prescribing for all ARTIs (both viral and bacterial), as well as rate of antibiotic prescription for only those ARTIs caused by viruses which would not require antibiotics by practice setting."
In what geographic regions is this investigation accessible?
"This research project is currently being carried out at 5 distinct sites, including Plantation and Philadelphia. To reduce potential inconveniences, it may be beneficial for patients to select the nearest location."
What type of subjects is this experiment best suited for?
"Eligibility requirements for this trial necessitate that participants possess sinusitis and fall within the 6 month to 12 year old age range. Up to 936 people are eligible to partake in the study."
Is there an upper age limit to be qualified for this investigation?
"This clinical trial requires participants aged 6 months to 12 years in order to meet the respective eligibility parameters."
Are additional participants being accepted for this investigation?
"According to clinicaltrials.gov, the recruitment period for this trial concluded on November 8th 2022. Nevertheless, there are currently 165 other studies actively seeking participants."
Share this study with friends
Copy Link
Messenger